Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease

Sandhoff disease (SD) is an autosomal recessive lysosomal storage disease caused by defects in the β-subunit of β-N-acetylhexosaminidase (Hex), the enzyme that catabolizes GM2 ganglioside (GM2). Hex deficiency causes neuronal storage of GM2 and related glycoconjugates, resulting in progressive neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: McCurdy, Victoria J., Johnson, Aime K., Gray-Edwards, Heather L., Randle, Ashley N., Bradbury, Allison M., Morrison, Nancy E., Hwang, Misako, Baker, Henry J., Cox, Nancy R., Sena-Esteves, Miguel, Martin, Douglas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925702/
https://www.ncbi.nlm.nih.gov/pubmed/32884151
http://dx.doi.org/10.1038/s41434-020-00190-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925702/
https://www.ncbi.nlm.nih.gov/pubmed/32884151
http://dx.doi.org/10.1038/s41434-020-00190-1

Ejemplares similares